Don't Write Off Pharma's Nightmare Scenario

Drug-price rhetoric translating into law is nearly unthinkable for investors, but the risk still shouldn’t be ignored.

from WSJ.com: Markets http://ift.tt/2n4BFxj
via https://ifttt.com/ IFTTT